Case Studies

<img width="796" height="600" src="https://fusionantibodies.com/wp-content/uploads/2019/04/Case-studies-e1562076983154.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" srcset="https://fusionantibodies.com/wp-content/uploads/2019/04/Case-studies-e1562076983154.jpg 796w, https://fusionantibodies.com/wp-content/uploads/2019/04/Case-studies-e1562076983154-300x226.jpg 300w, https://fusionantibodies.com/wp-content/uploads/2019/04/Case-studies-e1562076983154-768x579.jpg 768w" sizes="(max-width: 796px) 100vw, 796px" />

Humanized Antibody JF5 detects Aspergillus

Posted on 19th December 20188th October 2019

Towards translational ImmunoPET/MR imaging of invasive Pulmonary Aspergillosis: The Humanized Monoclonal Antibody JF5 detects Aspergillus Lung Infections in Vivo

<img width="600" height="500" src="https://fusionantibodies.com/wp-content/uploads/2019/03/feature-biomarker-v3jpg.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" srcset="https://fusionantibodies.com/wp-content/uploads/2019/03/feature-biomarker-v3jpg.jpg 600w, https://fusionantibodies.com/wp-content/uploads/2019/03/feature-biomarker-v3jpg-300x250.jpg 300w, https://fusionantibodies.com/wp-content/uploads/2019/03/feature-biomarker-v3jpg-357x298.jpg 357w" sizes="(max-width: 600px) 100vw, 600px" />

Potential biomarkers for bladder and colon cancer

Posted on 19th December 20182nd July 2019

Non-phosphorylated and Phosphorylated Signal Transduction Peptide (STP) of Tissue Factor (TF) in Urine are Potential Biomarkers for Bladder and Colon Cancer.

<img width="2560" height="1704" src="https://fusionantibodies.com/wp-content/uploads/2019/02/fusion-frozen-berries.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" srcset="https://fusionantibodies.com/wp-content/uploads/2019/02/fusion-frozen-berries.jpg 2560w, https://fusionantibodies.com/wp-content/uploads/2019/02/fusion-frozen-berries-300x200.jpg 300w, https://fusionantibodies.com/wp-content/uploads/2019/02/fusion-frozen-berries-1024x682.jpg 1024w, https://fusionantibodies.com/wp-content/uploads/2019/02/fusion-frozen-berries-768x511.jpg 768w, https://fusionantibodies.com/wp-content/uploads/2019/02/fusion-frozen-berries-1536x1022.jpg 1536w, https://fusionantibodies.com/wp-content/uploads/2019/02/fusion-frozen-berries-2048x1363.jpg 2048w, https://fusionantibodies.com/wp-content/uploads/2019/02/fusion-frozen-berries-357x238.jpg 357w" sizes="(max-width: 2560px) 100vw, 2560px" />

Fsn1006: An antibody with dual specificity

Posted on 15th November 201829th January 2020

Fsn1006 is a dual targeting antibody targeting both AREG (Amphiregulin) and HB-EGF (Heparin-binding EGF-like growth factor. The objective of this study was to humanize Fsn1006 while retaining the affinities.